FdaApplication
ANDA 214663
Identifiers
- fda_app_no: ANDA214663
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2022-03-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPLERENONE | EPLERENONE | 50MG | TABLET;ORAL |
| EPLERENONE | EPLERENONE | 25MG | TABLET;ORAL |
2 products